Potassium hydrogen DL-aspartate

DB15998InvestigationalSmall molecule

Potassium hydrogen DL-aspartate is a medication indicated to treat combined potassium-magnesium deficiency with subsequent arrhythmia. A medication used to treat an irregular heart beat.

Formula / weight: C₄H₆KNO₄ · 171.193 g/mol (avg)

Resolves to

Compound

UNII5UW00M8KR0CAS923-09-1

Structure

InChIKeyTXXVQZSTAVIHFD-UHFFFAOYSA-MSMILES[K+].NC(CC([O-])=O)C(O)=O

What you can answer from here — as of April 02, 2025

1Structured indicationCondition, population, route and combination as fields, not prose

16ContraindicationsEach with its own population and attribute set

3Marketed productsAcross 1 country and 1 labeller

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Potassium hydrogen DL-aspartate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account